Orbis

This retrospective study included 280 patients (166 women, 114 men) who underwent elective SA in a single center between November 2010 and October 2019. Data regarding demographic characteristics, diagnosis, treatment, and laboratory parameters were retrieved from the hospital information system (Orbis; AGFA Healthcare, Mortsel, Belgium).
Exclusion criteria were revision surgery, active inflammation or infection, known inflammatory diseases, neoplasia, liver cirrhosis, and postoperative complications within the three-month follow-up. Patients with elevated preoperative baseline CRP level > 1 mg/dL were also excluded (reference < 0.5 mg/dL).

We collected the data of all patients that underwent elective total hip and bicondylar knee arthroplasty between January 2016 and December 2018 in a single orthopaedic university hospital.
Demographic, anamnestic and clinical data were collected retrospectively from the hospital’s information technology system (ORBIS, Agfa Healthcare GmbH, Bonn, Germany). Data about the use of allogeneic and autologous blood transfusions were crosschecked using hard copy records. Of the demographic and anamnestic data, we recorded the patient’s age, sex, height and weight as well as the preoperative medication, daily consumption of alcohol or nicotine and comorbidities. Of the preoperative clinical data, we recorded the American Society of Anaesthesiologists (ASA) status and the lab values of the last blood sample before undergoing surgery, including c-reactive protein (mg/dL), haemoglobin concentration (g/dL), haematocrite (%), mean corpuscular volume (MCV) (fl), platelet count (10³/µL), creatinine (µmol/L), estimated glomerular filtration rate (eGFR) (mL/min) Quick (%) and partial thromboplastin time (PTT) (sec).
Of the intraoperative data, we collected the type of anaesthesia, the type of surgery, the use of tranexamic acid, duration of surgery, the use of drains and the use of an autologous re-transfusion system (cell saver).

Die Datenanalyse basierte auf den Patientenakten und dem Klinikinformationssystem Orbis (AGFA Health Care GmbH, Bonn, Deutschland). Die anonymisierte Datenaufbereitung erfolgte in MS Excel (Microsoft, Redmond, WA, USA).

The study was designed as a retrospective monocentric analysis including 46 patients with histologically confirmed nasopharyngeal carcinoma treated with radiotherapy or radiochemotherapy at our department between 2004 and 2021. Clinical data was collected via the electronic patient file as provided by our hospital information system (Orbis, Agfa Healthcare, Mortsel, Belgium) including medical reports, laboratory values, imaging and follow-up notes. Additional data on radiotherapy details were provided by the information system of the department of radiation oncology (Aria, Varian Medical Systems, Pao Alto, CA, USA) and the planning system Eclipse.
The study protocol was reviewed and approved by our local institutional review board and informed consent was given by all participants.

The present analysis was designed as a single-institutional retrospective study including all patients with histologically proven anal squamous cell carcinoma treated with RT or RCT at our department between May 2004 and January 2020. Ethical approval was granted by our local institutional review board. Clinical data were collected via the electronic patient file as provided by our hospital information system (Orbis, Agfa Healthcare, Mortsel, Belgium), including medical reports, laboratory values, imaging, and follow-up notes. Additional data on RT details were provided by the information system of the department of radiation oncology (Aria, Varian Medical Systems, Pao Alto, CA, USA).

All clinical data were collected from electronic patient files and medical records using the hospital documentation system ORBIS (Agfa Health Care N.V., Mortsel Belgium). Default settings for the interpretation of laboratory values and inflammation parameters were adopted from ORBIS. Body temperature above 38 °C was defined as fever, CRP was considered elevated if exceeding 0.5 mg/dL and leukocyte counts were considered normal between 3.9 and 10.9 × 10³/µL.

A retrospective chart review was performed at the Department of General, Visceral, Cancer, and Transplant Surgery in cooperation with the Interdisciplinary Endoscopy Unit at the University Hospital Cologne. Patients that underwent an oncological IL RAMIE with transthoracic gastric pull-up reconstruction and presented with an ECCG AL type II were included in the analysis.
Esophageal AL is defined according to the ECCG classification as a full thickness GI defect involving esophagus, anastomosis or staple line irrespective of presentation or method of identification. The leak were further classified as, Type I: local defect requiring no change in therapy or treated medically or with dietary modification; Type II: localized defect requiring interventional but not surgical therapy; Type III: localized defect requiring surgical therapy [20 (link)].
Data were retrieved from our prospectively maintained hospital database “Orbis” (version 08,043,703; Agfa HealthCare N.V., Belgium) and from our prospectively maintained endoscopic database “Clinic WinData” (version 8.06; E&L medical system GmbH, Erlangen, Germany). The following information was collected: demographic and clinical patient characteristics, details of the disease, leak characteristics, time to EVT, duration of EVT, and follow-up treatments.